|
|
|
|
|
|
|
· | On-going solicitation of investment in the Company in the form of private placements of common shares or debt securities; |
· | Continue to explore strategic joint ventures and technology licensing agreements to expand company revenue and cash flow; and |
· | Recently expanded and continue to optimize production of existing manufacturing capabilities to increase product revenues; |
| | June 30, | | ||||
| | 2015 | | 2014 | | ||
Common stock options and warrants | | | 4,063,253 | | | 8,090,878 | |
Non-vested restricted stock | | | 985,000 | | | | |
| | June 30, | | March 31, | | ||
| | 2015 | | 2015 | | ||
Raw materials and supplies | | $ | 60,831 | | $ | 58,390 | |
Work in process | | | 29,789 | | | 31,371 | |
Finished goods | | | 203,606 | | | 205,999 | |
| | $ | 294,226 | | $ | 295,760 | |
| | Years | |
Machinery and equipment | | 3 to15 | |
Furniture and fixtures | | 3 to10 | |
Engineering equipment | | 5 to 12 | |
|
| | | | June 30, | | March 31, | | ||
| | Life | | 2015 | | 2015 | | ||
Patents, gross | | 6.75 19.46 | | $ | 8,135,063 | | $ | 8,135,063 | |
In-process research and development | | Indefinite | | | 1,832,370 | | | 1,832,370 | |
| | | | | 9,967,433 | | | 9,967,433 | |
Accumulated amortization | | | | | (2,113,195) | | | (1,919,485) | |
Net intangible assets | | | | $ | 7,854,238 | | $ | 8,047,948 | |
Fiscal Year Ending | | | | |
Nine months ending March 31, 2016 | | $ | 581,130 | |
March 31, 2017 | | | 774,840 | |
March 31, 2018 | | | 774,840 | |
March 31, 2019 | | | 774,840 | |
March 31, 2020 | | | 595,159 | |
Thereafter | | $ | 2,521,059 | |
|
|
|
Restricted Stock | | Shares | | |
Restricted stock outstanding March 31, 2015 | | | | |
Granted | | | 985,000 | |
Vested | | | | |
Expired/cancelled | | | | |
Restricted stock outstanding June 30, 2015 | | | 985,000 | |
Options | | Shares | | Weighted- Average Exercise Price | | Weighted-Average Remaining Contractual Term | | |||
Employee options outstanding March 31, 2015 | | | 232,500 | | $ | 0.35 | | | 1.45 | |
Granted | | | 685,000 | | | 1.03 | | | 9.86 | |
Exercised | | | (5,625) | | | .33 | | | | |
Expired/cancelled | | | (210,000) | | | 0.83 | | | | |
Employee options outstanding June 30, 2015 | | | 701,875 | | $ | 0.87 | | | 7.80 | |
Exercisable at June 30, 2015 | | | 17,500 | | $ | 0.48 | | | 0.85 | |
| | | | | Weighted Average | | |
| | | | | Grant-Date | | |
Non-vested Shares | | Shares | | Fair Value | | ||
Non-vested at March 31, 2015 | | | 209,375 | | | 0.21 | |
Granted | | | 685,000 | | | 0.98 | |
Vested | | | | | | | |
Expired/cancelled: non-vested | | | (210,000) | | | 0.76 | |
Non-vested at June 30, 2015 | | | 684,375 | | $ | 0.81 | |
| | | Options Outstanding | | Options Exercisable | | |||||||||||
Range of Exercise Price | | Number Outstanding | | Weighted Average Remaining Contractual Life (years) | | Weighted Average Exercise Price | | Number of Shares | | Weighted Average Exercise Price | | ||||||
$ | 1.03 | | | 535,000 | | | 9.86 | | $ | 1.03 | | | | | $ | | |
$ | 0.80 | | | 7,500 | | | 0.02 | | | 0.80 | | | 5,500 | | | 0.80 | |
$ | 0.33 | | | 159,375 | | | 1.24 | | | 0.33 | | | 12,000 | | | 0.33 | |
| | | | 701,875 | | | 7.80 | | $ | 0.87 | | | 17,500 | | $ | 0.48 | |
|
|
|
Balance of ownership interest in joint venture at March 31,2015 | | $ | 30,041 | |
Aggregate fiscal 2016 equity gain share of joint venture income | | | 16,339 | |
Balance of ownership interest in joint venture at June 30, 2015 | | $ | 46,380 | |
| | | | |
Cumulative recognized income on ownership interest in joint venture at June 30, 2015 | | $ | 45,380 | |
Revenues | | $ | 260,299 | |
Expenses | | | 227,622 | |
Net Income | | $ | 32,677 | |
| | | | |
Total Assets | | $ | 611,259 | |
| | | | |
Total Liabilities | | $ | 518,499 | |
Total Partners Capital | | | 92,760 | |
Total Liabilities and Partner Capital | | $ | 611,259 | |
|
|
· | On-going solicitation of investment in the Company in the form of private placements of common shares or debt securities; |
· | Continue to explore strategic joint ventures and technology licensing agreements to expand company revenue and cash flow; and |
· | Recently expanded and continue to optimize production of existing manufacturing capabilities to increase product revenues; |
| | June 30, | | ||||
| | 2015 | | 2014 | | ||
Common stock options and warrants | | | 4,063,253 | | | 8,090,878 | |
Non-vested restricted stock | | | 985,000 | | | | |
| | June 30, | | March 31, | | ||
| | 2015 | | 2015 | | ||
Raw materials and supplies | | $ | 60,831 | | $ | 58,390 | |
Work in process | | | 29,789 | | | 31,371 | |
Finished goods | | | 203,606 | | | 205,999 | |
| | $ | 294,226 | | $ | 295,760 | |
| | Years | |
Machinery and equipment | | 3 to15 | |
Furniture and fixtures | | 3 to10 | |
Engineering equipment | | 5 to 12 | |
|
| | June 30, | | ||||
| | 2015 | | 2014 | | ||
Common stock options and warrants | | | 4,063,253 | | | 8,090,878 | |
Non-vested restricted stock | | | 985,000 | | | | |
| | June 30, | | March 31, | | ||
| | 2015 | | 2015 | | ||
Raw materials and supplies | | $ | 60,831 | | $ | 58,390 | |
Work in process | | | 29,789 | | | 31,371 | |
Finished goods | | | 203,606 | | | 205,999 | |
| | $ | 294,226 | | $ | 295,760 | |
| | Years | |
Machinery and equipment | | 3 to15 | |
Furniture and fixtures | | 3 to10 | |
Engineering equipment | | 5 to 12 | |
|
| | | | June 30, | | March 31, | | ||
| | Life | | 2015 | | 2015 | | ||
Patents, gross | | 6.75 19.46 | | $ | 8,135,063 | | $ | 8,135,063 | |
In-process research and development | | Indefinite | | | 1,832,370 | | | 1,832,370 | |
| | | | | 9,967,433 | | | 9,967,433 | |
Accumulated amortization | | | | | (2,113,195) | | | (1,919,485) | |
Net intangible assets | | | | $ | 7,854,238 | | $ | 8,047,948 | |
Fiscal Year Ending | | | | |
Nine months ending March 31, 2016 | | $ | 581,130 | |
March 31, 2017 | | | 774,840 | |
March 31, 2018 | | | 774,840 | |
March 31, 2019 | | | 774,840 | |
March 31, 2020 | | | 595,159 | |
Thereafter | | $ | 2,521,059 | |
|
Restricted Stock | | Shares | | |
Restricted stock outstanding March 31, 2015 | | | | |
Granted | | | 985,000 | |
Vested | | | | |
Expired/cancelled | | | | |
Restricted stock outstanding June 30, 2015 | | | 985,000 | |
Options | | Shares | | Weighted- Average Exercise Price | | Weighted-Average Remaining Contractual Term | | |||
Employee options outstanding March 31, 2015 | | | 232,500 | | $ | 0.35 | | | 1.45 | |
Granted | | | 685,000 | | | 1.03 | | | 9.86 | |
Exercised | | | (5,625) | | | .33 | | | | |
Expired/cancelled | | | (210,000) | | | 0.83 | | | | |
Employee options outstanding June 30, 2015 | | | 701,875 | | $ | 0.87 | | | 7.80 | |
Exercisable at June 30, 2015 | | | 17,500 | | $ | 0.48 | | | 0.85 | |
| | | | | Weighted Average | | |
| | | | | Grant-Date | | |
Non-vested Shares | | Shares | | Fair Value | | ||
Non-vested at March 31, 2015 | | | 209,375 | | | 0.21 | |
Granted | | | 685,000 | | | 0.98 | |
Vested | | | | | | | |
Expired/cancelled: non-vested | | | (210,000) | | | 0.76 | |
Non-vested at June 30, 2015 | | | 684,375 | | $ | 0.81 | |
| | | Options Outstanding | | Options Exercisable | | |||||||||||
Range of Exercise Price | | Number Outstanding | | Weighted Average Remaining Contractual Life (years) | | Weighted Average Exercise Price | | Number of Shares | | Weighted Average Exercise Price | | ||||||
$ | 1.03 | | | 535,000 | | | 9.86 | | $ | 1.03 | | | | | $ | | |
$ | 0.80 | | | 7,500 | | | 0.02 | | | 0.80 | | | 5,500 | | | 0.80 | |
$ | 0.33 | | | 159,375 | | | 1.24 | | | 0.33 | | | 12,000 | | | 0.33 | |
| | | | 701,875 | | | 7.80 | | $ | 0.87 | | | 17,500 | | $ | 0.48 | |
|
Balance of ownership interest in joint venture at March 31,2015 | | $ | 30,041 | |
Aggregate fiscal 2016 equity gain share of joint venture income | | | 16,339 | |
Balance of ownership interest in joint venture at June 30, 2015 | | $ | 46,380 | |
| | | | |
Cumulative recognized income on ownership interest in joint venture at June 30, 2015 | | $ | 45,380 | |
Revenues | | $ | 260,299 | |
Expenses | | | 227,622 | |
Net Income | | $ | 32,677 | |
| | | | |
Total Assets | | $ | 611,259 | |
| | | | |
Total Liabilities | | $ | 518,499 | |
Total Partners Capital | | | 92,760 | |
Total Liabilities and Partner Capital | | $ | 611,259 | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|